Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Risk factors for adrenal insufficiency after adrenalectomy for mild autonomous cortisol secretion.

Surgery·2026

Same author

Reoperative adrenalectomy: Indications and outcomes.

American journal of surgery·2025

Same author

Reoperative Thyroid Procedures: Do They Pose a Higher Risk of Complications Compared to First-Time Surgery?

The Journal of surgical research·2025

Same author

Learner and Teacher Entrustability Concordance in Endocrine Surgery Entrustable Professional Activities.

World journal of surgery·2025

Same author

Renal function after adrenalectomy in patients with primary aldosteronism.

Surgery·2025

Same author

Adrenal imaging features and associated pathologic diagnoses: A contemporary, longitudinal analysis.

Surgery·2025

Same journal

Preoperative Predictors of Close or Compromised Surgical Margins in Patients With Oral Squamous Cell Carcinoma.

Head & neck·2026

Same journal

Neoadjuvant Immunochemotherapy Reduces Major Wound Complications in Oral Cancer Surgery.

Head & neck·2026

Same journal

Botulinum Toxin for First Bite Syndrome: A Symptom-Guided "Follow-The-Pain" Injection Strategy.

Head & neck·2026

Same journal

The Impact of Margin Status Following Surgery for Metastatic Cutaneous Squamous Cell Carcinoma to the Parotid Gland.

Head & neck·2026

Same journal

Feasibility and Acceptability of a Co-Designed Model of Prehabilitation for Head and Neck Cancer Patients Undergoing Radiotherapy.

Head & neck·2026

Same journal

Neurocognitive Function in Head and Neck Cancer Patients Prior to Radiation Therapy.

Head & neck·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 30, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Predicting malignancy in thyroid nodules: molecular advances.

Adrienne L Melck¹, Linwah Yip

¹Section of Endocrine Surgery, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

|August 6, 2011

Summary

This summary is machine-generated.

Identifying genetic alterations in thyroid cancer aids in managing indeterminate thyroid nodules. Molecular markers like BRAF and microRNAs show promise for predicting malignancy and guiding surgical decisions.

More Related Videos

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Experiment Videos

Last Updated: May 30, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Area of Science:

Oncology
Genetics
Endocrinology

Background:

Thyroid cancer diagnosis often requires surgery due to limitations in current diagnostic tools.
Indeterminate thyroid nodules present a clinical challenge, necessitating improved diagnostic accuracy.

Purpose of the Study:

To review the role of molecular markers in diagnosing thyroid nodules.
To summarize current literature and institutional findings on specific genetic alterations.
To present an updated management algorithm incorporating molecular markers.

Main Methods:

Literature review of genetic alterations in thyroid carcinogenesis.
Analysis of prospective data on biomarkers including BRAF, RAS, PAX8-PPARγ, microRNAs, and LOH.
Development of a management algorithm for thyroid nodules.

Main Results:

Several molecular markers (BRAF, RAS, PAX8-PPARγ, microRNAs, LOH) show potential for predicting malignancy.
These markers can aid in differentiating benign from malignant thyroid nodules.
Incorporation of molecular data can refine surgical management strategies.

Conclusions:

Molecular markers offer improved diagnostic accuracy for indeterminate thyroid nodules.
These tools can help personalize treatment and reduce unnecessary surgeries.
An integrated approach using molecular data enhances thyroid nodule management.